相似文献
1
Behavioral Problems in Fragile X Syndrome: A Review of Clinical Management.
Cureus. 2022 Feb 2;14(2):e21840. doi: 10.7759/cureus.21840. eCollection 2022 Feb.
2
Fragile X syndrome: A review of clinical management.
Intractable Rare Dis Res. 2016 Aug;5(3):145-57. doi: 10.5582/irdr.2016.01048.
3
A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene.
J Vis Exp. 2019 Sep 16(151). doi: 10.3791/59963.
4
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12.
5
Fragile X premutation and associated health conditions: A review.
Clin Genet. 2021 Jun;99(6):751-760. doi: 10.1111/cge.13924. Epub 2021 Jan 24.
6
Modeling fragile X syndrome in the Fmr1 knockout mouse.
Intractable Rare Dis Res. 2014 Nov;3(4):118-33. doi: 10.5582/irdr.2014.01024.
7
[Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].
Dev Period Med. 2018;22(1):14-21. doi: 10.34763/devperiodmed.20182201.1421.
8
Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual.
Exp Cell Res. 2021 Jan 15;398(2):112419. doi: 10.1016/j.yexcr.2020.112419. Epub 2020 Dec 6.
9
Molecular analysis of fragile X syndrome (FXS) among Malaysian patients with developmental disability.
Malays J Pathol. 2017 Aug;39(2):99-106.
10
Fragile X spectrum disorders.
Intractable Rare Dis Res. 2014 Nov;3(4):134-46. doi: 10.5582/irdr.2014.01022.
引用本文的文献
1
Systematic Review: Fragile X Syndrome Across the Lifespan with a Focus on Genetics, Neurodevelopmental, Behavioral and Psychiatric Associations.
Genes (Basel). 2025 Jan 25;16(2):149. doi: 10.3390/genes16020149.
2
Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome.
Int J Mol Sci. 2024 Nov 26;25(23):12718. doi: 10.3390/ijms252312718.
3
Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases.
Mol Neurobiol. 2024 Dec;61(12):10722-10735. doi: 10.1007/s12035-024-04239-9. Epub 2024 May 23.
4
Quality of life of Brazilian families who have children with Fragile X syndrome: a descriptive study.
J Community Genet. 2023 Aug;14(4):407-418. doi: 10.1007/s12687-023-00660-0. Epub 2023 Aug 18.
5
A Double Jeopardy: Loss of FMRP Results in DSB and Down-regulated DNA Repair.
21 Century Pathol. 2022;2(5). Epub 2022 Oct 17.
6
Epilepsy Characteristics in Neurodevelopmental Disorders: Research from Patient Cohorts and Animal Models Focusing on Autism Spectrum Disorder.
Int J Mol Sci. 2022 Sep 16;23(18):10807. doi: 10.3390/ijms231810807.
本文引用的文献
1
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
Neurotherapeutics. 2022 Jan;19(1):248-262. doi: 10.1007/s13311-022-01183-1. Epub 2022 Jan 14.
2
Fragile X Syndrome in a Female With Homozygous Full-Mutation Alleles of the FMR1 Gene.
Cureus. 2021 Jul 12;13(7):e16340. doi: 10.7759/cureus.16340. eCollection 2021 Jul.
3
Telehealth-enabled behavioral treatment for problem behaviors in boys with fragile X syndrome: a randomized controlled trial.
J Neurodev Disord. 2020 Nov 20;12(1):31. doi: 10.1186/s11689-020-09331-4.
4
Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment.
Mol Autism. 2020 May 27;11(1):41. doi: 10.1186/s13229-020-00350-5.
5
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome.
J Neurodev Disord. 2020 Apr 22;12(1):12. doi: 10.1186/s11689-020-09315-4.
6
Metformin treatment in young children with fragile X syndrome.
Mol Genet Genomic Med. 2019 Nov;7(11):e956. doi: 10.1002/mgg3.956. Epub 2019 Sep 14.
7
A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
J Neurodev Disord. 2019 Aug 2;11(1):16. doi: 10.1186/s11689-019-9277-x.
8
New Targeted Treatments for Fragile X Syndrome.
Curr Pediatr Rev. 2019;15(4):251-258. doi: 10.2174/1573396315666190625110748.
9
Management of Self-injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview.
Pharmacotherapy. 2019 Jun;39(6):645-664. doi: 10.1002/phar.2238. Epub 2019 Mar 27.
10
ASD Comorbidity in Fragile X Syndrome: Symptom Profile and Predictors of Symptom Severity in Adolescent and Young Adult Males.
J Autism Dev Disord. 2019 Mar;49(3):960-977. doi: 10.1007/s10803-018-3796-2.
Zotero 插件